Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron vs Pethidine for Post-Spinal Shivering in C-Section
NCT06513806Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Aug 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of granisetron in post-spinal shivering (PSS) (2 arms), sponsored by Ain Shams University. Primary endpoint: Treating post spinal shivering. Started Aug 2024; status: completed.
02
Drugs
granisetron
03
Conditions
post-spinal shivering (PSS)
Beyond the preview
Go deeper on NCT06513806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06513806.